000 01673 a2200457 4500
005 20250511201647.0
264 0 _c19910729
008 199107s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-199104000-00006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNishiyama, S
245 0 0 _aA novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cApr 1991
300 _a560-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnesthesia
650 0 4 _aAnimals
650 0 4 _aBenzazepines
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDepression, Chemical
650 0 4 _aDogs
650 0 4 _aDomperidone
_xpharmacology
650 0 4 _aDopamine
_xanalogs & derivatives
650 0 4 _aDopamine Antagonists
650 0 4 _aGuinea Pigs
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aProdrugs
_xpharmacology
650 0 4 _aReceptors, Dopamine D1
650 0 4 _aReceptors, Dopamine D2
650 0 4 _aRegional Blood Flow
_xdrug effects
650 0 4 _aRenal Circulation
_xdrug effects
650 0 4 _aVasodilator Agents
700 1 _aYoshikawa, M
700 1 _aYamaguchi, I
773 0 _tJournal of cardiovascular pharmacology
_gvol. 17
_gno. 4
_gp. 560-7
856 4 0 _uhttps://doi.org/10.1097/00005344-199104000-00006
_zAvailable from publisher's website
999 _c1718022
_d1718022